<p>Tilray Brands, Inc.（納斯達克代碼：TLRY - 獲取免費報告）在週五的交易中股價下跌了 2.7%。該公司的股價最低曾達到 6.65 美元，最後交易價為 6.75 美元。在午盤交易中，共交易了 8,470,793 股，較平均交易量 4,503,807 股增加了 88%。該股票之前的收盤價為 6.94 美元。</p>
<p>獲取 <strong>Tilray Brands</strong> 的提醒：</p>
<h2>Tilray Brands 重要新聞</h2>
<ul>
<li>大麻行業的十億美元減税</li>
</ul>
<p>以下是本週影響 Tilray Brands 的主要新聞：</p>
<ul>
<li>積極情緒：聯邦重新分類（從第一類到第三類）顯著改善了美國大麻運營商的税收前景，並引發了行業反彈；雖然 Tilray 更像是一個全球/手工飲料的參與者（因此是一個同情受益者），但政策變化對大麻投資者情緒總體上是利好的。閲讀更多。</li>
<li>積極情緒：Tilray 發佈聲明，表明公司將加速美國醫療擴展，並強調其品牌飲料和健康渠道，為潛在的上行提供了敍述，如果監管准入實現。閲讀更多。</li>
<li>積極情緒：大量異常的看漲期權購買表明投機性看漲頭寸，可能會放大日內反彈（和波動性）。閲讀更多。</li>
<li>積極情緒：至少一位華爾街分析師（Roth Capital）持樂觀態度，並給 Tilray 設定了一個可觀的上行情景，這支持了動量驅動的買入。閲讀更多。</li>
<li>中性情緒：首席執行官的採訪和媒體報道強化了公司圍繞美國機會的戰略敍述，但管理層尚未提供具體的新美國收入或時間表指導。閲讀更多。</li>
<li>中性情緒：在日內激增期間，交易經歷了 LULD/波動暫停——這是一種市場機制，反映了快速變動而非基本面的變化。（沒有單一文章；在市場報道中提及。）</li>
<li>消極情緒：內部人士拋售：一名公司董事出售了 33,556 股（已披露的 4 號表格），交易員對此表示關注，可能導致了獲利了結。閲讀更多。</li>
<li>消極情緒：“賣出新聞” 反轉和稀釋擔憂：在第三類標題發佈後的早期漲幅消退，交易員獲利了結，而一份關於市場發行（最高約 1.8 億美元）的四月招股説明書重新引發了稀釋擔憂——給股價施加壓力。閲讀更多。</li>
<li>消極情緒：日內報道指出，在盤前激增後迅速回落——這一模式（跳漲後回落）強調今天的走勢更多是由政策頭條和動量交易驅動，而非 Tilray 公司層面的即時收益或現金流改善。閲讀更多。</li>
</ul>
<h2>分析師設定新目標價</h2>
<p>多家券商最近對 TLRY 發表了評論。ATB Cormark Capital Markets 在 4 月 2 日的研究報告中將 Tilray Brands 的目標價從 9.50 美元下調至 9.00 美元，並對該股票設定了 “行業表現” 評級。Weiss Ratings 在 1 月 21 日的研究報告中重新發布了對 Tilray Brands 的 “賣出（d-）” 評級。Wall Street Zen 在 3 月 21 日的研究報告中將 Tilray Brands 的評級從 “賣出” 上調至 “持有”。Roth Mkm 在 4 月 2 日的研究報告中將 Tilray Brands 的評級從 “中性” 上調至 “買入”，並設定了 10.00 美元的目標價。最後，TD Cowen 在 3 月 30 日的研究報告中將 Tilray Brands 的目標價從 10.00 美元下調至 7.00 美元，並對該股票設定了 “買入” 評級。三位股票研究分析師對該股票給予了 “買入” 評級，四位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Tilray Brands 的共識評級為 “持有”，平均目標價為 11.50 美元。</p>
<ul>
<li>2026 年大麻黑馬：税改如何重置股票估值</li>
</ul>
<p><strong>查看我們關於 Tilray Brands 的最新研究報告</strong></p>
<h2>Tilray Brands 價格表現</h2>
<p>該公司的市值為 7.8671 億美元，市盈率為-0.49，貝塔值為 2.00。公司的債務與股本比率為 0.19，速動比率為 1.66，流動比率為 2.79。該公司的 50 日移動平均線為 7.03 美元，200 日移動平均線為 9.51 美元。</p>
<ul>
<li>MarketBeat 週報 – 09/29 - 10/03</li>
</ul>
<p>Tilray Brands（納斯達克代碼：TLRY - 獲取免費報告）最後一次發佈季度財報是在 4 月 1 日，報告顯示該季度每股收益（EPS）為-0.24 美元，低於市場共識預期的-0.14 美元，差距為-0.10 美元。該季度的營業收入為 2.0673 億美元，而市場共識預期為 2.0135 億美元。Tilray Brands 的淨利潤率為-156.51%，股本回報率為-3.31%。去年同期，該公司每股收益為-0.87 美元。分析師預測 Tilray Brands, Inc.在當前年度將發佈-0.55 美元的每股收益。</p>
<h2>Tilray Brands 的內部交易</h2>
<p>在相關消息中，董事 David G. Hopkinson 在 4 月 21 日的交易中出售了 33,556 股公司的股票。該股票的平均售價為 6.94 美元，總價值為 232,878.64 美元。該交易已在 SEC 的法律文件中披露，可通過 SEC 網站獲取。公司內部人士持有公司股票的 0.84%。</p>
<h2>機構投資者對 Tilray Brands 的看法</h2>
<p>對沖基金最近增加或減少了對該股票的持股。Tudor Investment Corp ET AL 在第三季度購買了價值 518,000 美元的 Tilray Brands 新股份。Optiver Holding B.V. 在第三季度將其在 Tilray Brands 的持股增加了 239.4%。Optiver Holding B.V. 目前擁有 224,049 股該公司股票，價值 388,000 美元，此前在上個季度又購買了 158,041 股。Cresset Asset Management LLC 在第三季度將其在 Tilray Brands 的持股增加了 72.1%。Cresset Asset Management LLC 目前擁有 501,989 股該公司股票，價值 868,000 美元，此前在上個季度又購買了 210,267 股。Caitong International Asset Management Co. Ltd 在第三季度將其在 Tilray Brands 的持股增加了 99,204,800.0%。Caitong International Asset Management Co. Ltd 目前擁有 992,049 股該公司股票，價值 1,716,000 美元，此前在上個季度又購買了 992,048 股。最後，Zuckerman Investment Group LLC 在第三季度購買了價值 147,000 美元的 Tilray Brands 新股份。目前，9.35% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Tilray Brands 公司簡介</h2>
<p>(獲取免費報告)</p>
<p>Tilray Brands, Inc 是一家全球性的 cannabis-lifestyle 和消費包裝商品公司，專注於大麻及其衍生產品的種植、生產、分銷和銷售。該公司開發和營銷多樣化的品牌產品組合，涵蓋醫療大麻、成人娛樂產品和健康產品。通過先進的種植設施、研發努力和質量控制系統，Tilray Brands 旨在為各種患者和消費者需求提供一致、可擴展的產品。</p>
<p>Tilray 的產品線包括大麻花、預捲煙、油和酊劑、電子煙、食品和外用產品，以及大麻衍生的 CBD 產品。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Tilray Brands</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Tilray Brands 嗎？</h2>
<p>在考慮 Tilray Brands 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Tilray Brands 並不在名單上。</p>
<p>雖然 Tilray Brands 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

TLRY

另類收益 ETF -ETFMG

純大麻 ETF - AdvisorShares

<p>Tilray Brands（納斯達克代碼：TLRY）股價在交易中下跌 2.7%，至 6.75 美元，成交量顯著增加。由於聯邦對大麻的重新分類，公司周圍的情緒積極，這可能會促進美國醫療市場的擴展。然而，內部人士的拋售和稀釋擔憂對股價表現產生了負面影響。分析師的評級不一，普遍持有評級，平均目標價為 11.50 美元。公司報告每股虧損 0.24 美元，未能達到預期，淨利潤率為負的 156.51%</p>

<p>Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) shares fell 2.7% during trading on Friday . The company traded as low as $6.65 and last traded at $6.75. 8,470,793 shares were traded during mid-day trading, an increase of 88% from the average session volume of 4,503,807 shares. The stock had previously closed at $6.94.</p>
<div class="lb-trans"><p>Tilray Brands, Inc.（納斯達克代碼：TLRY - 獲取免費報告）在週五的交易中股價下跌了 2.7%。該公司的股價最低曾達到 6.65 美元，最後交易價為 6.75 美元。在午盤交易中，共交易了 8,470,793 股，較平均交易量 4,503,807 股增加了 88%。該股票之前的收盤價為 6.94 美元。</p>
</div><p>Get <strong>Tilray Brands</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Tilray Brands</strong> 的提醒：</p>
</div><h2>Key Tilray Brands News</h2>
<div class="lb-trans"><h2>Tilray Brands 重要新聞</h2>
</div><ul>
<li>The Cannabis Sector's Billion-Dollar Tax Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻行業的十億美元減税</li>
</ul>
</div><p>Here are the key news stories impacting Tilray Brands this week:</p>
<div class="lb-trans"><p>以下是本週影響 Tilray Brands 的主要新聞：</p>
</div><ul>
<li>Positive Sentiment: Federal rescheduling (Schedule I → III) materially improves the tax outlook for U.S. cannabis operators and has ignited a sector rally; while Tilray is more of a global/craft‑beverage play (so it's a sympathy beneficiary), the policy shift is broadly bullish for cannabis investor sentiment. Read More.</li>
<li>Positive Sentiment: Tilray issued statements positioning the company to accelerate U.S. medical expansion and highlight its branded beverage and wellness channels, providing a narrative for upside if regulatory access materializes. Read More.</li>
<li>Positive Sentiment: Large, unusual call‑option buying suggests speculative bullish positioning that can amplify intraday rallies (and volatility). Read More.</li>
<li>Positive Sentiment: At least one Wall Street analyst (Roth Capital) is bullish and has given Tilray a sizable upside scenario, which supports momentum-driven buying. Read More.</li>
<li>Neutral Sentiment: CEO interviews and media coverage reinforce the company’s strategic narrative around U.S. opportunity, but management has not yet provided concrete new U.S. revenue or timeline guidance. Read More.</li>
<li>Neutral Sentiment: Trading experienced a LULD/volatility pause during the intraday surge — a market mechanism reflecting fast moves rather than changing fundamentals. (No single article; referenced in market coverage.)</li>
<li>Negative Sentiment: Insider selling: a company director sold 33,556 shares (disclosed Form 4), which traders flagged and may have contributed to profit-taking. Read More.</li>
<li>Negative Sentiment: “Sell‑the‑news” reversal and dilution concerns: early gains after the Schedule III headline faded as traders took profits, and an April prospectus for an at‑the‑market offering (up to ~$180M) resurfaced dilution worries—pressuring the stock. Read More.</li>
<li>Negative Sentiment: Intraday coverage noted rapid fade after the premarket surge — the pattern (jump then giveback) underscores that today's move was driven more by policy headlines and momentum trading than by an immediate, company-level earnings or cash‑flow improvement for Tilray. Read More.</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：聯邦重新分類（從第一類到第三類）顯著改善了美國大麻運營商的税收前景，並引發了行業反彈；雖然 Tilray 更像是一個全球/手工飲料的參與者（因此是一個同情受益者），但政策變化對大麻投資者情緒總體上是利好的。閲讀更多。</li>
<li>積極情緒：Tilray 發佈聲明，表明公司將加速美國醫療擴展，並強調其品牌飲料和健康渠道，為潛在的上行提供了敍述，如果監管准入實現。閲讀更多。</li>
<li>積極情緒：大量異常的看漲期權購買表明投機性看漲頭寸，可能會放大日內反彈（和波動性）。閲讀更多。</li>
<li>積極情緒：至少一位華爾街分析師（Roth Capital）持樂觀態度，並給 Tilray 設定了一個可觀的上行情景，這支持了動量驅動的買入。閲讀更多。</li>
<li>中性情緒：首席執行官的採訪和媒體報道強化了公司圍繞美國機會的戰略敍述，但管理層尚未提供具體的新美國收入或時間表指導。閲讀更多。</li>
<li>中性情緒：在日內激增期間，交易經歷了 LULD/波動暫停——這是一種市場機制，反映了快速變動而非基本面的變化。（沒有單一文章；在市場報道中提及。）</li>
<li>消極情緒：內部人士拋售：一名公司董事出售了 33,556 股（已披露的 4 號表格），交易員對此表示關注，可能導致了獲利了結。閲讀更多。</li>
<li>消極情緒：“賣出新聞” 反轉和稀釋擔憂：在第三類標題發佈後的早期漲幅消退，交易員獲利了結，而一份關於市場發行（最高約 1.8 億美元）的四月招股説明書重新引發了稀釋擔憂——給股價施加壓力。閲讀更多。</li>
<li>消極情緒：日內報道指出，在盤前激增後迅速回落——這一模式（跳漲後回落）強調今天的走勢更多是由政策頭條和動量交易驅動，而非 Tilray 公司層面的即時收益或現金流改善。閲讀更多。</li>
</ul>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>A number of brokerages have recently commented on TLRY. ATB Cormark Capital Markets dropped their price target on Tilray Brands from $9.50 to $9.00 and set a &#34;sector perform&#34; rating on the stock in a research report on Thursday, April 2nd. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Tilray Brands in a research report on Wednesday, January 21st. Wall Street Zen raised Tilray Brands from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, March 21st. Roth Mkm raised Tilray Brands from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $10.00 price target on the stock in a research report on Thursday, April 2nd. Finally, TD Cowen lowered their price objective on Tilray Brands from $10.00 to $7.00 and set a &#34;buy&#34; rating on the stock in a research report on Monday, March 30th. Three equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Tilray Brands has a consensus rating of &#34;Hold&#34; and an average price target of $11.50.</p>
<div class="lb-trans"><p>多家券商最近對 TLRY 發表了評論。ATB Cormark Capital Markets 在 4 月 2 日的研究報告中將 Tilray Brands 的目標價從 9.50 美元下調至 9.00 美元，並對該股票設定了 “行業表現” 評級。Weiss Ratings 在 1 月 21 日的研究報告中重新發布了對 Tilray Brands 的 “賣出（d-）” 評級。Wall Street Zen 在 3 月 21 日的研究報告中將 Tilray Brands 的評級從 “賣出” 上調至 “持有”。Roth Mkm 在 4 月 2 日的研究報告中將 Tilray Brands 的評級從 “中性” 上調至 “買入”，並設定了 10.00 美元的目標價。最後，TD Cowen 在 3 月 30 日的研究報告中將 Tilray Brands 的目標價從 10.00 美元下調至 7.00 美元，並對該股票設定了 “買入” 評級。三位股票研究分析師對該股票給予了 “買入” 評級，四位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Tilray Brands 的共識評級為 “持有”，平均目標價為 11.50 美元。</p>
</div><ul>
<li>The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations</li>
</ul>
<div class="lb-trans"><ul>
<li>2026 年大麻黑馬：税改如何重置股票估值</li>
</ul>
</div><p><strong>Check Out Our Latest Research Report on Tilray Brands</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Tilray Brands 的最新研究報告</strong></p>
</div><h2>Tilray Brands Price Performance</h2>
<div class="lb-trans"><h2>Tilray Brands 價格表現</h2>
</div><p>The firm has a market capitalization of $786.71 million, a P/E ratio of -0.49 and a beta of 2.00. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.66 and a current ratio of 2.79. The firm has a 50-day moving average of $7.03 and a 200-day moving average of $9.51.</p>
<div class="lb-trans"><p>該公司的市值為 7.8671 億美元，市盈率為-0.49，貝塔值為 2.00。公司的債務與股本比率為 0.19，速動比率為 1.66，流動比率為 2.79。該公司的 50 日移動平均線為 7.03 美元，200 日移動平均線為 9.51 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 09/29 - 10/03</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週報 – 09/29 - 10/03</li>
</ul>
</div><p>Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings data on Wednesday, April 1st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.10). The business had revenue of $206.73 million during the quarter, compared to the consensus estimate of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period last year, the company posted ($0.87) earnings per share. As a group, analysts predict that Tilray Brands, Inc. will post -0.55 EPS for the current year.</p>
<div class="lb-trans"><p>Tilray Brands（納斯達克代碼：TLRY - 獲取免費報告）最後一次發佈季度財報是在 4 月 1 日，報告顯示該季度每股收益（EPS）為-0.24 美元，低於市場共識預期的-0.14 美元，差距為-0.10 美元。該季度的營業收入為 2.0673 億美元，而市場共識預期為 2.0135 億美元。Tilray Brands 的淨利潤率為-156.51%，股本回報率為-3.31%。去年同期，該公司每股收益為-0.87 美元。分析師預測 Tilray Brands, Inc.在當前年度將發佈-0.55 美元的每股收益。</p>
</div><h2>Insider Transactions at Tilray Brands</h2>
<div class="lb-trans"><h2>Tilray Brands 的內部交易</h2>
</div><p>In related news, Director David G. Hopkinson sold 33,556 shares of the company's stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $6.94, for a total value of $232,878.64. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.84% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事 David G. Hopkinson 在 4 月 21 日的交易中出售了 33,556 股公司的股票。該股票的平均售價為 6.94 美元，總價值為 232,878.64 美元。該交易已在 SEC 的法律文件中披露，可通過 SEC 網站獲取。公司內部人士持有公司股票的 0.84%。</p>
</div><h2>Institutional Investors Weigh In On Tilray Brands</h2>
<div class="lb-trans"><h2>機構投資者對 Tilray Brands 的看法</h2>
</div><p>Hedge funds have recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL purchased a new stake in Tilray Brands during the 3rd quarter valued at $518,000. Optiver Holding B.V. raised its stake in Tilray Brands by 239.4% during the 3rd quarter. Optiver Holding B.V. now owns 224,049 shares of the company's stock valued at $388,000 after buying an additional 158,041 shares during the last quarter. Cresset Asset Management LLC raised its stake in Tilray Brands by 72.1% during the 3rd quarter. Cresset Asset Management LLC now owns 501,989 shares of the company's stock valued at $868,000 after buying an additional 210,267 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its stake in Tilray Brands by 99,204,800.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 992,049 shares of the company's stock valued at $1,716,000 after buying an additional 992,048 shares during the last quarter. Finally, Zuckerman Investment Group LLC purchased a new stake in Tilray Brands during the 3rd quarter valued at $147,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>對沖基金最近增加或減少了對該股票的持股。Tudor Investment Corp ET AL 在第三季度購買了價值 518,000 美元的 Tilray Brands 新股份。Optiver Holding B.V. 在第三季度將其在 Tilray Brands 的持股增加了 239.4%。Optiver Holding B.V. 目前擁有 224,049 股該公司股票，價值 388,000 美元，此前在上個季度又購買了 158,041 股。Cresset Asset Management LLC 在第三季度將其在 Tilray Brands 的持股增加了 72.1%。Cresset Asset Management LLC 目前擁有 501,989 股該公司股票，價值 868,000 美元，此前在上個季度又購買了 210,267 股。Caitong International Asset Management Co. Ltd 在第三季度將其在 Tilray Brands 的持股增加了 99,204,800.0%。Caitong International Asset Management Co. Ltd 目前擁有 992,049 股該公司股票，價值 1,716,000 美元，此前在上個季度又購買了 992,048 股。最後，Zuckerman Investment Group LLC 在第三季度購買了價值 147,000 美元的 Tilray Brands 新股份。目前，9.35% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Tilray Brands Company Profile</h2>
<div class="lb-trans"><h2>Tilray Brands 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.</p>
<div class="lb-trans"><p>Tilray Brands, Inc 是一家全球性的 cannabis-lifestyle 和消費包裝商品公司，專注於大麻及其衍生產品的種植、生產、分銷和銷售。該公司開發和營銷多樣化的品牌產品組合，涵蓋醫療大麻、成人娛樂產品和健康產品。通過先進的種植設施、研發努力和質量控制系統，Tilray Brands 旨在為各種患者和消費者需求提供一致、可擴展的產品。</p>
</div><p>Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.</p>
<div class="lb-trans"><p>Tilray 的產品線包括大麻花、預捲煙、油和酊劑、電子煙、食品和外用產品，以及大麻衍生的 CBD 產品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Tilray Brands</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Tilray Brands</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tilray Brands Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Tilray Brands 嗎？</h2>
</div><p>Before you consider Tilray Brands, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Tilray Brands 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Tilray Brands 並不在名單上。</p>
</div><p>While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Tilray Brands 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Tilray Brands（NASDAQ:TLRY）股價下跌 2.7% - 以下是原因